-
Antihistamines likely offer no meaningful benefit for eczema and may increase harms
Adding oral antihistamines to existing eczema treatments is unlikely to lead to clinically important reductions in eczema and itch severity... Read more -
Blocking a mitochondrial transporter may curb inflammation from 'zombie' cells without killing them
Researchers have uncovered a previously unknown mechanism that helps aging cells drive the chronic inflammation linked to many age-related diseases.... Read more -
Scientists develop microRNA-based gene therapy that halts ALS progression in mice
A single IV injection of a microRNA-based biologic developed by Guangping Gao, Ph.D., Robert H. Brown Jr., DPhil, MD, Jun... Read more -
Can oral semaglutide reduce alcohol use? Clinical trial shows fewer heavy drinking days
A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes... Read more -
Povorcitinib beneficial for moderate-to-severe hidradenitis suppurativa
For patients with moderate-to-severe hidradenitis suppurativa (HS), povorcitinib (an oral Janus kinase 1 inhibitor) is beneficial, according to a study... Read more -
The lightbulb moment behind a potential antiviral breakthrough
An unexpected observation by a University of Queensland researcher could lead to a new treatment for deadly infectious diseases including... Read more -
New study identifies behaviors influencing prescribing decisions for new medicines in neurodegenerative diseases
A new pan-European study has identified the key behavioral factors that influence whether health care professionals prescribe new, novel or... Read more -
GLP-1 drugs may hold few benefits beyond physical health, study finds
GLP-1 medications such as Ozempic have transformed the treatment of type 2 diabetes, helping millions of patients better control their... Read more -
New study reveals how blood cancers outsmart BTK-targeted therapies
Scientists at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and collaborators have uncovered... Read more -
Results from trial show THC/CBD combination significantly reduces agitation for people with dementia at end of life
A combination of CBD and THC rapidly and significantly reduces agitation in hospice-eligible people with dementia, suggest top-line results from... Read more -
Remdesivir for COVID-19 linked to better outcomes for adult kidney transplant recipients
Adults with kidney transplants who were treated for COVID-19 with the antiviral remdesivir within a week of a COVID-19 diagnosis... Read more -
Lifelong supplementation reduced midlife mortality risk in mice
Maintaining and improving quality of life (QOL) and extending a healthy lifespan are among the most important objectives for an... Read more -
Longevity medicine has gone peptide-crazy
If there's a word that captures both the great promise and the persistent uncertainty of longevity medicine, it's peptides.... Read more -
HIV progress in 'real danger' as global funding plummets
The science has never been better, but political will has reached a new low: AIDS experts warned Monday that the... Read more -
New patent could pave the way for more effective growth hormone therapies
A newly filed patent from researchers at Ohio University could help develop more effective treatments for disorders related to growth... Read more
